Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Hepatitis C

Free Subscription Articles published in J Viral Hepat Retrieve available abstracts of 161 articles: HTML format Text format

Single Articles

February 2012
1. MARUOKA D , Imazeki F, Arai M, Kanda T, et al
   Longitudinal changes of the laboratory data of chronic hepatitis C patients with sustained virological response on long-term follow-up.
   J Viral Hepat. 2012;19:e97-e104.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
2. GROVER VP , Pavese N, Koh SB, Wylezinska M, et al
   Cerebral microglial activation in patients with hepatitis c: in vivo evidence of neuroinflammation.
   J Viral Hepat. 2012;19:e89-e96.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
3. BACHMETOV L , Gal-Tanamy M, Shapira A, Vorobeychik M, et al
   Suppression of hepatitis C virus by the flavonoid quercetin is mediated by inhibition of NS3 protease activity.
   J Viral Hepat. 2012;19:e81-e88.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
4. RANCE E , Tanner JE, Alfieri C
   Inhibition of IkappaB kinase by thalidomide increases hepatitis C virus RNA replication.
   J Viral Hepat. 2012;19:e73-80.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
5. KAWAGUCHI T , Ide T, Itou M, Suetsugu M, et al
   Ischaemic colitis during interferon treatment for chronic hepatitis C: report of two cases and literature review.
   J Viral Hepat. 2012;19:e220-4.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
6. ALMARIO CV , Vega M, Trooskin SB, Navarro VJ, et al
   Examining hepatitis c virus testing practices in primary care clinics.
   J Viral Hepat. 2012;19:e163-9.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
7. CHENG JC , Yeh YJ, Huang YH, Liang KH, et al
   Hepatic expression of MxA and OAS1 in an ex vivo liver slice assay independently predicts treatment outcomes in chronic hepatitis C.
   J Viral Hepat. 2012;19:e154-62.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
8. CALES P , Zarski JP, Marc Chapplain J, Bertrais S, et al
   Fibrosis progression under maintenance interferon in hepatitis C is better detected by blood test than liver morphometry.
   J Viral Hepat. 2012;19:e143-e153.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
9. HAYASHI N , Okanoue T, Tsubouchi H, Toyota J, et al
   Efficacy and safety of telaprevir, a new protease inhibitor, for difficult-to-treat patients with genotype 1 chronic hepatitis C.
   J Viral Hepat. 2012;19:e134-e142.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
10. MIKI D , Ohishi W, Ochi H, Hayes CN, et al
    Serum PAI-1 is a novel predictor for response to pegylated interferon-alpha-2b plus ribavirin therapy in chronic hepatitis C virus infection.
    J Viral Hepat. 2012;19:e126-e133.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
11. CRAXI A , Koutsounas S, Ogurtsov P, Chemello L, et al
    Peginterferon alfa-2b plus weight-based ribavirin for 24 weeks in patients with chronic hepatitis C virus genotype 1 with low viral load who achieve rapid viral response.
    J Viral Hepat. 2012;19:e120-e125.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
12. YAMADA I , Suzuki F, Kamiya N, Aoki K, et al
    Safety, pharmacokinetics and resistant variants of telaprevir alone for 12 weeks in hepatitis C virus genotype 1b infection.
    J Viral Hepat. 2012;19:e112-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
13. HO EY , Ha NB, Ahmed A, Ayoub W, et al
    Prospective study of risk factors for hepatitis C virus acquisition by Caucasian, Hispanic, and Asian American patients.
    J Viral Hepat. 2012;19:e105-11.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
14. KATSOUNAS A , Trippler M, Wang B, Polis M, et al
    CCL5 mRNA is a marker for early fibrosis in chronic hepatitis C and is regulated by interferon-alpha therapy and toll-like receptor 3 signalling.
    J Viral Hepat. 2012;19:128-37.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
15. VERMEHREN J , Susser S, Lange CM, Forestier N, et al
    Mutations selected in the hepatitis C virus NS3 protease domain during sequential treatment with boceprevir with and without pegylated interferon alfa-2b.
    J Viral Hepat. 2012;19:120-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
16. JAFFERBHOY H , Miller MH, Dunbar JK, Tait J, et al
    Intravenous drug use: not a barrier to achieving a sustained virological response in HCV infection.
    J Viral Hepat. 2012;19:112-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
17. REAU N , Hamzeh FM, Lentz E, Zhou X, et al
    Characterization of nonrapid virologic response patients infected with HCV genotype 1 who may relapse after standard therapy with peginterferon plus ribavirin.
    J Viral Hepat. 2012;19:94-102.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
18. ALAVIAN SM , Tabatabaei SV, Behnava B
    Impact of erythropoietin on sustained virological response to peginterferon and ribavirin therapy for HCV infection: a systematic review and meta-analysis.
    J Viral Hepat. 2012;19:88-93.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
19. STICKEL F , Helbling B, Heim M, Geier A, et al
    Critical review of the use of erythropoietin in the treatment of anaemia during therapy for chronic hepatitis C.
    J Viral Hepat. 2012;19:77-87.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2012
20. ALBERSTEIN M , Zornitzki T, Zick Y, Knobler H, et al
    Hepatitis C core protein impairs insulin downstream signalling and regulatory role of IGFBP-1 expression.
    J Viral Hepat. 2012;19:65-71.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
21. HOPE V , Parry JV, Marongui A, Ncube F, et al
    Hepatitis C infection among recent initiates to injecting in England 2000-2008: Is a national hepatitis C action plan making a difference?
    J Viral Hepat. 2012;19:55-64.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
22. CIESEK S , Wedemeyer H
    Immunosuppression, liver injury and post-transplant HCV recurrence.
    J Viral Hepat. 2012;19:1-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
23. KRONENBERGER B , Zeuzem S
    New developments in HCV therapy.
    J Viral Hepat. 2012;19 Suppl 1:48-51.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
24. NEGRO F
    Steatosis and insulin resistance in response to treatment of chronic hepatitis C.
    J Viral Hepat. 2012;19 Suppl 1:42-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
25. RUMI M , Aghemo A, Prati GM
    Comparative trials of peginterferon alpha2a and peginterferon alpha2b for chronic hepatitis C.
    J Viral Hepat. 2012;19 Suppl 1:37-41.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
26. SEBASTIANI G , Alberti A
    How far is noninvasive assessment of liver fibrosis from replacing liver biopsy in hepatitis C?
    J Viral Hepat. 2012;19 Suppl 1:18-32.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
27. SIMON-TALERO M , Buti M, Esteban R
    Severe anaemia related to oseltamivir during treatment of chronic hepatitis C: a new drug interaction?
    J Viral Hepat. 2012;19 Suppl 1:14-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
28. FERENCI P
    Optimal treatment duration for patients with HCV genotype 1 infection.
    J Viral Hepat. 2012;19 Suppl 1:7-13.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
29. DEGASPERI E , Aghemo A
    Clinical drivers in naive patient eligibility for treatment of chronic hepatitis C.
    J Viral Hepat. 2012;19 Suppl 1:3-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    December 2011
30. FABRIZI F , Dixit V, Martin P, Messa P, et al
    Hepatitis C virus and the immunological response to hepatitis B virus vaccine in dialysis patients: meta-analysis of clinical studies.
    J Viral Hepat. 2011;18:871-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
31. RYAN EJ , Stevenson NJ, Hegarty JE, O'Farrelly C, et al
    Chronic hepatitis C infection blocks the ability of dendritic cells to secrete IFN-alpha and stimulate T-cell proliferation.
    J Viral Hepat. 2011;18:840-51.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2011
32. BARAKAT SH , El-Bashir N
    Hepatitis C virus infection among healthy Egyptian children: prevalence and risk factors.
    J Viral Hepat. 2011;18:779-84.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
33. PROBST A , Dang T, Bochud M, Egger M, et al
    Role of Hepatitis C virus genotype 3 in liver fibrosis progression - a systematic review and meta-analysis.
    J Viral Hepat. 2011;18:745-759.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2011
34. DE ALMEIDA BS , Fabricio Silva GM, da Silva PM, de Mello Perez R, et al
    Ethnicity and route of HCV infection can influence the associations of HLA with viral clearance in an ethnically heterogeneous population.
    J Viral Hepat. 2011;18:692-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
35. SANCHEZ-CONDE M , Miralles P, Maria Bellon J, Rincon D, et al
    Use of transient elastography (FibroScan((R)) ) for the noninvasive assessment of portal hypertension in HIV/HCV-coinfected patients.
    J Viral Hepat. 2011;18:685-91.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
36. ESLAM M , Kawaguchi T, Del Campo JA, Sata M, et al
    Use of HOMA-IR in hepatitis C.
    J Viral Hepat. 2011;18:675-84.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
37. FRANCO S , Bellido R, Aparicio E, Canete N, et al
    Natural prevalence of HCV minority variants that are highly resistant to NS3/4A protease inhibitors.
    J Viral Hepat. 2011;18:e578-82.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
38. GHOSH S , Ahrens WA, Phatak SU, Hwang S, et al
    Association of filamin A and vimentin with hepatitis C virus proteins in infected human hepatocytes.
    J Viral Hepat. 2011;18:e568-77.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
39. CHUNG H , Watanabe T, Kudo M, Chiba T, et al
    Correlation between hyporesponsiveness to Toll-like receptor ligands and liver dysfunction in patients with chronic hepatitis C virus infection.
    J Viral Hepat. 2011;18:e561-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
40. KAWAOKA T , Aikata H, Takaki S, Hiramatsu A, et al
    IL28B polymorphism may guide pegylated interferon plus ribavirin therapy even after curative treatment for hepatitis C virus-related hepatocellular carcinoma.
    J Viral Hepat. 2011;18:e550-60.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
41. ROQUE-CUELLAR MC , Sanchez B, Garcia-Lozano JR, Praena-Fernandez JM, et al
    Cellular immune responses and occult infection in seronegative heterosexual partners of chronic hepatitis C patients.
    J Viral Hepat. 2011;18:e541-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
42. ABDEL-HADY M , Bunn SK, Sira J, Brown RM, et al
    Chronic hepatitis C in children - review of natural history at a National Centre.
    J Viral Hepat. 2011;18:e535-40.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
43. LIM AK , Patel N, Eckersley RJ, Fitzpatrick J, et al
    A comparison of (31) P magnetic resonance spectroscopy and microbubble-enhanced ultrasound for characterizing hepatitis c-related liver disease.
    J Viral Hepat. 2011;18:e530-4.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
44. YAO L , Dong H, Zhu H, Nelson D, et al
    Identification of the IFITM3 gene as an inhibitor of hepatitis C viral translation in a stable STAT1 cell line.
    J Viral Hepat. 2011;18:e523-e529.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
45. NKONTCHOU G , Ziol M, Aout M, Lhabadie M, et al
    HCV genotype 3 is associated with a higher hepatocellular carcinoma incidence in patients with ongoing viral C cirrhosis.
    J Viral Hepat. 2011;18:e516-22.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
46. GARCIA-FULGUEIRAS A , Garcia-Pina R, Morant C, Fernandez de Larrea-Baz N, et al
    Burden of disease related to hepatitis C and hepatitis B in Spain: a methodological challenge of an unfolding health problem.
    J Viral Hepat. 2011;18:e453-60.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2011
47. RYAN EJ , O'Farrelly C
    The affect of chronic hepatitis C infection on dendritic cell function: a summary of the experimental evidence.
    J Viral Hepat. 2011;18:601-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
48. GALMOZZI E , Del Menico B, Rametta R, Dongiovanni P, et al
    A tetra-primer amplification refractory mutation system polymerase chain reaction for the evaluation of rs12979860 IL28B genotype.
    J Viral Hepat. 2011;18:628-30.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
49. HATZAKIS A , Wait S, Bruix J, Buti M, et al
    The state of hepatitis B and C in Europe: report from the hepatitis B and C summit conference*.
    J Viral Hepat. 2011;18 Suppl 1:1-16.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2011
50. ENGLAND K , Thorne C, Harris H, Ramsay M, et al
    The impact of mode of acquisition on biological markers of paediatric hepatitis C virus infection.
    J Viral Hepat. 2011;18:533-41.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
51. STASI C , Zignego AL, Laffi G, Rosselli M, et al
    The liver-cytokine-brain circuit in interferon-based treatment of patients with chronic viral hepatitis.
    J Viral Hepat. 2011;18:525-32.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2011
52. DI MARTINO V , Crouzet J, Hillon P, Thevenot T, et al
    Long-term outcome of chronic hepatitis C in a population-based cohort and impact of antiviral therapy: a propensity-adjusted analysis.
    J Viral Hepat. 2011;18:493-505.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
53. TANDON P , Doucette K, Fassbender K, Vandermeer B, et al
    Granulocyte colony-stimulating factor for hepatitis C therapy-associated neutropenia: systematic review and economic evaluation.
    J Viral Hepat. 2011;18:e381-93.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
54. PETTA S , Di Marco V, Di Stefano R, Cabibi D, et al
    TyG index, HOMA score and viral load in patients with chronic hepatitis C due to genotype 1.
    J Viral Hepat. 2011;18:e372-80.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
55. COREY KE , Mendez-Navarro J, Barlow LL, Patwardhan V, et al
    Acute hepatitis C infection lowers serum lipid levels.
    J Viral Hepat. 2011;18:e366-71.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
56. VIGNIER N , Esmat G, Sharkawy AE, Hassany M, et al
    Reproducibility of liver stiffness measurements in hepatitis C virus (HCV)-infected patients in Egypt.
    J Viral Hepat. 2011;18:e358-e365.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
57. RUIZ-MATEOS E , Machmach K, Romero-Sanchez MC, Ferrando-Martinez S, et al
    Hepatitis C virus replication in Caucasian HIV controllers.
    J Viral Hepat. 2011;18:e350-e357.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
58. MOLLER JF , Moller B, Wiedenmann B, Berg T, et al
    CD154, a marker of antigen-specific stimulation of CD4 T cells, is associated with response to treatment in patients with chronic HCV infection.
    J Viral Hepat. 2011;18:e341-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
59. COX J , Graves L, Marks E, Tremblay C, et al
    Knowledge, attitudes and behaviours associated with the provision of hepatitis C care by Canadian family physicians.
    J Viral Hepat. 2011;18:e332-40.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
60. LINDH M , Lagging M, Arnholm B, Eilard A, et al
    IL28B polymorphisms determine early viral kinetics and treatment outcome in patients receiving peginterferon/ribavirin for chronic hepatitis C genotype 1.
    J Viral Hepat. 2011;18:e325-31.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
61. LEE JC , Tseng CK, Wu SF, Chang FR, et al
    San-Huang-Xie-Xin-Tang extract suppresses hepatitis C virus replication and virus-induced cyclooxygenase-2 expression.
    J Viral Hepat. 2011;18:e315-24.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
62. LOKO MA , Bani-Sadr F, Winnock M, Lacombe K, et al
    Impact of HAART exposure and associated lipodystrophy on advanced liver fibrosis in HIV/HCV-coinfected patients.
    J Viral Hepat. 2011;18:e307-e314.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
63. AHN DG , Shim SB, Moon JE, Kim JH, et al
    Interference of hepatitis C virus replication in cell culture by antisense peptide nucleic acids targeting the X-RNA.
    J Viral Hepat. 2011;18:e298-306.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
64. AKKIZ H , Bayram S, Bekar A, Akgollu E, et al
    A functional polymorphism in pre-microRNA-196a-2 contributes to the susceptibility of hepatocellular carcinoma in a Turkish population: a case-control study.
    J Viral Hepat. 2011;18:e399-407.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
65. REDDICK KL , Jhaveri R, Gandhi M, James AH, et al
    Pregnancy outcomes associated with viral hepatitis.
    J Viral Hepat. 2011;18:e394-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
66. THEIN HH , Walter SR, Gidding HF, Amin J, et al
    Trends in incidence of hepatocellular carcinoma after diagnosis of hepatitis B or C infection: a population-based cohort study, 1992-2007.
    J Viral Hepat. 2011;18:e232-e241.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2011
67. MORIKAWA K , Lange CM, Gouttenoire J, Meylan E, et al
    Nonstructural protein 3-4A: the Swiss army knife of hepatitis C virus.
    J Viral Hepat. 2011;18:305-15.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    April 2011
68. ARSHAD M , El-Kamary SS, Jhaveri R
    Hepatitis C virus infection during pregnancy and the newborn period - are they opportunities for treatment?
    J Viral Hepat. 2011;18:229-36.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
69. PRITCHETT S , Cardenas A, Manning D, Curry M, et al
    The optimal cut-off for predicting large oesophageal varices using transient elastography is disease specific.
    J Viral Hepat. 2011;18:e75-80.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
70. TILLMANN HL , Wiese M, Braun Y, Wiegand J, et al
    Quality of life in patients with various liver diseases: patients with HCV show greater mental impairment, while patients with PBC have greater physical impairment.
    J Viral Hepat. 2011;18:252-61.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2011
71. PHAM TN , Coffin CS, Churchill ND, Urbanski SJ, et al
    Hepatitis C virus persistence after sustained virological response to antiviral therapy in patients with or without past exposure to hepatitis B virus.
    J Viral Hepat. 2011 Mar 1. doi: 10.1111/j.1365-2893.2011.01442.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2011
72. MOREL V , Fournier C, Francois C, Brochot E, et al
    Genetic recombination of the hepatitis C virus: clinical implications.
    J Viral Hepat. 2011;18:77-83.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2011
73. BLANCO F , Barreiro P, Ryan P, Vispo E, et al
    Risk factors for advanced liver fibrosis in HIV-infected individuals: role of antiretroviral drugs and insulin resistance.
    J Viral Hepat. 2011;18:11-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    December 2010
74. KRUEGER C , Hawkins K, Wong S, Enns MW, et al
    Persistent pro-inflammatory cytokines following the initiation of pegylated IFN therapy in hepatitis C infection is associated with treatment-induced depression.
    J Viral Hepat. 2010 Dec 8. doi: 10.1111/j.1365-2893.2010.01408.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
75. LAWSON A
    A comparison of the natural history and outcome of treatment for Asian and non-Asian hepatitis C-infected patients.
    J Viral Hepat. 2010 Dec 7. doi: 10.1111/j.1365-2893.2010.01406.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
76. MARTINEZ AD , Dimova R, Marks KM, Beeder AB, et al
    Integrated internist - addiction medicine - hepatology model for hepatitis C management for individuals on methadone maintenance.
    J Viral Hepat. 2010 Dec 3. doi: 10.1111/j.1365-2893.2010.01411.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
77. KANDA T , Imazeki F, Yonemitsu Y, Mikami S, et al
    Quantification of hepatitis C virus in patients treated with peginterferon-alfa 2a plus ribavirin treatment by COBAS TaqMan HCV test.
    J Viral Hepat. 2010 Dec 3. doi: 10.1111/j.1365-2893.2010.01409.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
78. SANCHEZ-CONDE M , Montes Ramirez ML, Bellon Cano JM, Caminoa A, et al
    Impact of liver steatosis on the correlation between liver stiffness and fibrosis measured by transient elastography in patients coinfected with human immunodeficiency virus and hepatitis C virus.
    J Viral Hepat. 2010 Dec 3. doi: 10.1111/j.1365-2893.2010.01407.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
79. UEDA Y , Marusawa H, Kaido T, Ogura Y, et al
    Effect of maintenance therapy with low-dose peginterferon for recurrent hepatitis C after living donor liver transplantation.
    J Viral Hepat. 2010 Dec 3. doi: 10.1111/j.1365-2893.2010.01398.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2010
80. BLOME MA , Bjorkman P, Flamholc L, Jacobsson H, et al
    Minimal transmission of HIV despite persistently high transmission of hepatitis C virus in a Swedish needle exchange program.
    J Viral Hepat. 2010 Nov 29. doi: 10.1111/j.1365-2893.2010.01400.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
81. VAN VLERKEN LG , Huisman EJ, Van Soest H, Boland GJ, et al
    Ribavirin rather than PEG-interferon pharmacodynamics predict nonresponse to antiviral therapy in naive chronic hepatitis C patients.
    J Viral Hepat. 2010 Nov 29. doi: 10.1111/j.1365-2893.2010.01399.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
82. FABRIZI F , Dixit V, Martin P, Messa P, et al
    Combined antiviral therapy of hepatitis C virus in dialysis patients: meta-analysis of clinical trials.
    J Viral Hepat. 2010 Nov 25. doi: 10.1111/j.1365-2893.2010.01405.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
83. DERBALA MF , Amer AM, Almohanadi M, John A, et al
    Hepatitis C virus genotype 4 with normal transaminases: histological changes, schistosomiasis and response to treatment.
    J Viral Hepat. 2010 Nov 25. doi: 10.1111/j.1365-2893.2010.01403.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
84. MUIR AJ , Hu KQ, Gordon SC, Koury K, et al
    Hepatitis C treatment among racial and ethnic groups in the IDEAL trial.
    J Viral Hepat. 2010 Nov 25. doi: 10.1111/j.1365-2893.2010.01402.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
85. SUN SC , Bae A, Qi X, Harris J, et al
    Natural variation in drug susceptibility to HCV polymerase inhibitors in treatment-naive HCV patient isolates.
    J Viral Hepat. 2010 Nov 25. doi: 10.1111/j.1365-2893.2010.01396.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
86. ZHOU YQ , Wang XH, Hong GH, Zhu Y, et al
    Twenty-four weeks of pegylated interferon plus ribavirin effectively treat patients with HCV genotype 6a.
    J Viral Hepat. 2010 Nov 24. doi: 10.1111/j.1365-2893.2010.01373.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
87. CLAUSEN LN , Weis N, Astvad K, Schonning K, et al
    Interleukin-28B polymorphisms are associated with hepatitis C virus clearance and viral load in a HIV-1-infected cohort.
    J Viral Hepat. 2010 Nov 12. doi: 10.1111/j.1365-2893.2010.01392.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
88. RAMCHARRAN D , Wahed AS, Conjeevaram HS, Evans RW, et al
    Serum lipids and their associations with viral levels and liver disease severity in a treatment-naive chronic hepatitis C type 1-infected cohort.
    J Viral Hepat. 2010 Nov 10. doi: 10.1111/j.1365-2893.2010.01394.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
89. SOCKALINGAM S , Links PS, Abbey SE
    Suicide risk in hepatitis C and during interferon-alpha therapy: a review and clinical update.
    J Viral Hepat. 2010 Nov 10. doi: 10.1111/j.1365-2893.2010.01393.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
90. BERZSENYI MD , Roberts SK, Preiss S, Woollard DJ, et al
    Hepatic TLR2 & TLR4 expression correlates with hepatic inflammation and TNF-alpha in HCV & HCV/HIV infection.
    J Viral Hepat. 2010 Nov 3. doi: 10.1111/j.1365-2893.2010.01390.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2010
91. VIGANI AG , Macedo de Oliveira A, Tozzo R, Pavan MH, et al
    The association of cryoglobulinaemia with sustained virological response in patients with chronic hepatitis C.
    J Viral Hepat. 2010 Oct 25. doi: 10.1111/j.1365-2893.2010.01385.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
92. MCDONALD SA , Hutchinson SJ, Mills PR, Bird SM, et al
    The influence of hepatitis C and alcohol on liver-related morbidity and mortality in Glasgow's injecting drug user population.
    J Viral Hepat. 2010 Oct 22. doi: 10.1111/j.1365-2893.2010.01380.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
93. KUMTHIP K , Pantip C, Chusri P, Thongsawat S, et al
    Correlation between mutations in the core and NS5A genes of hepatitis C virus genotypes 1a, 1b, 3a, 3b, 6f and the response to pegylated interferon and ribavirin combination therapy.
    J Viral Hepat. 2010 Oct 19. doi: 10.1111/j.1365-2893.2010.01379.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
94. PARIKH M , Singh A, Sood G
    Extended treatment duration for treatment naive chronic hepatitis C genotype 1 late viral responders: a meta-analysis comparing 48 weeks vs 72 weeks of pegylated interferon and ribavirin.
    J Viral Hepat. 2010 Oct 18. doi: 10.1111/j.1365-2893.2010.01374.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
95. KRAUSKOPF K , McGinn TG, Federman AD, Halm EA, et al
    HIV and HCV health beliefs in an inner-city community.
    J Viral Hepat. 2010 Oct 18. doi: 10.1111/j.1365-2893.2010.01383.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
96. MCDONALD SA , Hutchinson SJ, Cameron S, Bird SM, et al
    Uptake of hepatitis C antibody testing in patients with end-stage liver disease in Glasgow, 1993-2007.
    J Viral Hepat. 2010 Oct 3. doi: 10.1111/j.1365-2893.2010.01377.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2010
97. MAUSS S , Hueppe D, John C, Goelz J, et al
    Estimating the likelihood of sustained virological response in chronic hepatitis C therapy.
    J Viral Hepat. 2010 Sep 16. doi: 10.1111/j.1365-2893.2010.01372.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
98. GREBELY J , Bryant J, Hull P, Hopwood M, et al
    Factors associated with specialist assessment and treatment for hepatitis C virus infection in New South Wales, Australia.
    J Viral Hepat. 2010 Sep 14. doi: 10.1111/j.1365-2893.2010.01370.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2010
99. MARTIN-CARBONERO L , Tuma P, Vispo E, Medrano J, et al
    Treatment of chronic hepatitis C in HIV-infected patients with compensated liver cirrhosis.
    J Viral Hepat. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
100. WANG CS , Chang TT, Yao WJ, Wang ST, et al
     The impact of smoking on incident type 2 diabetes in a cohort with hepatitis B but not hepatitis C infection.
     J Viral Hepat. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
101. LOUIE KS , Micallef JM, Pimenta JM, Forssen UM, et al
     Prevalence of thrombocytopenia among patients with chronic hepatitis C: a systematic review.
     J Viral Hepat. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
102. GIANNINI EG , Savarino V
     Epidemiology of thrombocytopenia in patients with chronic hepatitis C: more than meets the eye.
     J Viral Hepat. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
103. GIESELER RK , Marquitan G, Schlattjan M, Sowa JP, et al
     Hepatocyte apoptotic bodies encasing nonstructural HCV proteins amplify hepatic stellate cell activation: implications for chronic hepatitis C.
     J Viral Hepat. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
104. YAMINI D , Basseri B, Chee GM, Arakelyan A, et al
     Tobacco and other factors have a negative impact on quality of life in hepatitis C patients.
     J Viral Hepat. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
105. GUEDJ J , Rong L, Dahari H, Perelson AS, et al
     A perspective on modelling hepatitis C virus infection.
     J Viral Hepat. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
106. IWATA R , Stieger B, Mertens JC, Muller T, et al
     The role of bile acid retention and a common polymorphism in the ABCB11 gene as host factors affecting antiviral treatment response in chronic hepatitis C.
     J Viral Hepat. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
107. LANDI A , Yu H, Babiuk LA, van Drunen Littel-van den Hurk S, et al
     Human dendritic cells expressing hepatitis C virus core protein display transcriptional and functional changes consistent with maturation.
     J Viral Hepat. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
108. ARAUJO ES , Dahari H, Neumann AU, de Paula Cavalheiro N, et al
     Very early prediction of response to HCV treatment with PEG-IFN-alfa-2a and ribavirin in HIV/HCV-coinfected patients.
     J Viral Hepat. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
109. SUTTI S , Vidali M, Mombello C, Sartori M, et al
     Conformational anti-cytochrome P4502E1 (CYP2E1) auto-antibodies contribute to necro-inflammatory injury in chronic hepatitis C.
     J Viral Hepat. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
110. BOODRAM B , Hershow RC, Klinzman D, Stapleton JT, et al
     GB virus C infection among young, HIV-negative injection drug users with and without hepatitis C virus infection.
     J Viral Hepat. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     July 2010
111. LAO XQ , Thompson A, McHutchison JG, McCarthy JJ, et al
     Sex and age differences in lipid response to chronic infection with the hepatitis C virus in the United States National Health and Nutrition Examination Surveys.
     J Viral Hepat. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
112. FLYNN JK , Dore GJ, Hellard M, Yeung B, et al
     Early IL-10 predominant responses are associated with progression to chronic hepatitis C virus infection in injecting drug users.
     J Viral Hepat. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     June 2010
113. BURGEL B , Friesland M, Koch A, Manns MP, et al
     Hepatitis C virus enters human peripheral neuroblastoma cells - evidence for extra-hepatic cells sustaining hepatitis C virus penetration.
     J Viral Hepat. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
114. BRETT HAUBER A , Mohamed AF, Beam C, Medjedovic J, et al
     Patient preferences and assessment of likely adherence to hepatitis C virus treatment.
     J Viral Hepat. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
115. PICKETT BE , Striker R, Lefkowitz EJ
     Evidence for separation of HCV subtype 1a into two distinct clades.
     J Viral Hepat. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
116. HOFER H , Aydin I, Neumueller-Guber S, Mueller C, et al
     Prevalence and clinical significance of GB virus type C/hepatitis G virus coinfection in patients with chronic hepatitis C undergoing antiviral therapy.
     J Viral Hepat. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
117. LINAS BP , Wang B, Smurzynski M, Losina E, et al
     The impact of HIV/HCV co-infection on health care utilization and disability: results of the ACTG Longitudinal Linked Randomized Trials (ALLRT) Cohort.
     J Viral Hepat. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
118. PUOTI C , Barbarini G, Picardi A, Romano M, et al
     Rapid virological response as a predictor of sustained response in HCV-infected patients with persistently normal alanine aminotransferase levels: A multicenter study.
     J Viral Hepat. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
119. HAMMOND T , Lee S, Watson MW, Flexman JP, et al
     Decreased IFNgamma production correlates with diminished production of cytokines by dendritic cells in patients infected with hepatitis C virus and receiving therapy.
     J Viral Hepat. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     May 2010
120. GROESSL EJ , Weingart KR, Stepnowsky CJ, Gifford AL, et al
     The hepatitis C self-management programme: a randomized controlled trial.
     J Viral Hepat. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
121. CAO F , Donlin MJ, Turner K, Cheng X, et al
     Genetic and biochemical diversity in the HCV NS5B RNA polymerase in the context of interferon alpha plus ribavirin therapy.
     J Viral Hepat. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
122. LINDH M , Arnholm B, Eilard A, Farkkila M, et al
     Hepatitis C treatment response kinetics and impact of baseline predictors.
     J Viral Hepat. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
123. SOUTHERN WN , Drainoni ML, Smith BD, Christiansen CL, et al
     Hepatitis C testing practices and prevalence in a high-risk urban ambulatory care setting.
     J Viral Hepat. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
124. DELGADO-BORREGO A , Kamegaya Y, Jordan SH, Agrawal S, et al
     HCV synergizes with body weight in the promotion of insulin resistance.
     J Viral Hepat. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
125. BARRETT L , Gallant M, Howley C, Ian Bowmer M, et al
     Stronger hepatitis C virus-specific CD8(+) T-cell responses in HIV coinfection.
     J Viral Hepat. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
126. SOLDEVILA B , Alonso N, Martinez-Arconada MJ, Morillas RM, et al
     A prospective study of T- and B-lymphocyte subpopulations, CD81 expression levels on B cells and regulatory CD4CD25CD127FoxP3 T cells in patients with chronic HCV infection during pegylated interferon-alpha2a plus ribavirin treatment.
     J Viral Hepat. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
127. WATANABE T , Bertoletti A, Tanoto TA
     PD-1/PD-L1 pathway and T-cell exhaustion in chronic hepatitis virus infection.
     J Viral Hepat. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
128. STRICKLAND GT
     Risk factors for HCV infection in Pakistan.
     J Viral Hepat. 2010;17:305-6.
     PubMed     Text format     Related articles   
     
     
     
     April 2010
129. DE QUEIROZ AT , Maracaja-Coutinho V, Jardim AC, Rahal P, et al
     Relation of pretreatment sequence diversity in NS5A region of HCV genotype 1 with immune response between pegylated-INF/ribavirin therapy outcomes.
     J Viral Hepat. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
130. HOPE VD , Hickman M, Ngui SL, Jones S, et al
     Measuring the incidence, prevalence and genetic relatedness of hepatitis C infections among a community recruited sample of injecting drug users, using dried blood spots.
     J Viral Hepat. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
131. MEDRANO J , Resino S, Vispo E, Madejon A, et al
     Hepatitis C virus (HCV) treatment uptake and changes in the prevalence of HCV genotypes in HIV/HCV-coinfected patients.
     J Viral Hepat. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
132. MO H , Yang C, Wang K, Wang Y, et al
     Estimation of inhibitory quotient using a comparative equilibrium dialysis assay for prediction of viral response to hepatitis C virus inhibitors.
     J Viral Hepat. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
133. PEDERSEN C , Alsio A, Lagging M, Langeland N, et al
     Ribavirin plasma concentration is a predictor of sustained virological response in patients treated for chronic hepatitis C virus genotype 2/3 infection.
     J Viral Hepat. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     March 2010
134. WELKER MW , Welsch C, Ochs D, Hofmann WP, et al
     Comparison of Envelope 2 CD81 binding regions in PBMC-derived versus serum-derived hepatitis C virus isolates: higher conservation of CD81 region 2 in PBMC isolates.
     J Viral Hepat. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
135. VELLOZZI C , Buchacz K, Baker R, Spradling PR, et al
     Treatment of hepatitis C virus (HCV) infection in patients coinfected with HIV in the HIV Outpatient Study (HOPS), 1999-2007.
     J Viral Hepat. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
136. PATEL K , Jhaveri R, George J, Qiang G, et al
     Open-label, ascending dose, prospective cohort study evaluating the antiviral efficacy of Rosuvastatin therapy in serum and lipid fractions in patients with chronic hepatitis C.
     J Viral Hepat. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
137. HAYASHI K , Katano Y, Ishigami M, Itoh A, et al
     Mutations in the core and NS5A region of hepatitis C virus genotype 1b and correlation with response to pegylated-interferon-alpha 2b and ribavirin combination therapy.
     J Viral Hepat. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
138. DZYUBLYK I , Yegorova T, Moroz L, Popovych O, et al
     Controlled release recombinant human interferon-alpha(2b) for treating patients with chronic hepatitis C genotype 1: a phase 2a clinical trial.
     J Viral Hepat. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
139. LEE WC , Wu TJ, Chou HS, Lee CF, et al
     Flexible and individualized treatment to achieve sustained viral response for recurrent hepatitis C in liver transplant recipients.
     J Viral Hepat. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
140. GADALLA SM , Preiss LR, Eyster ME, Goedert JJ, et al
     Correlates of high hepatitis C virus RNA load in a cohort of HIV-negative and HIV-positive individuals with haemophilia.
     J Viral Hepat. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
141. KRISTIANSEN MG , Lochen ML, Gutteberg TJ, Mortensen L, et al
     Total and cause-specific mortality rates in a prospective study of community-acquired hepatitis C virus infection in northern Norway.
     J Viral Hepat. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
142. CHEN TM , Huang PT, Wen CF, Tung JN, et al
     Reappraisal of the importance of mutations in the NS5A-PKR-binding domain of hepatitis C-1b virus in the era of optimally individualized therapy.
     J Viral Hepat. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     February 2010
143. RYAN MC , Desmond PV, Slavin JL, Congiu M, et al
     Expression of genes involved in lipogenesis is not increased in patients with HCV genotype 3 in human liver.
     J Viral Hepat. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
144. WESTIN J , Hellstrand K, Dhillon AP, Lagging M, et al
     Are FoxP3(+) cells involved in hyporesponsiveness to interferon/ribavirin therapy in chronic hepatitis C?
     J Viral Hepat. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
145. KALLMAN JB , Tran S, Arsalla A, Haddad D, et al
     Vietnamese community screening for hepatitis B virus and hepatitis C virus.
     J Viral Hepat. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
146. GREBELY J , Raffa JD, Lai C, Kerr T, et al
     Impact of hepatitis C virus infection on all-cause and liver-related mortality in a large community-based cohort of inner city residents.
     J Viral Hepat. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
147. FU Y , Wang Y, Xia W, Pybus OG, et al
     New trends of HCV infection in China revealed by genetic analysis of viral sequences determined from first-time volunteer blood donors.
     J Viral Hepat. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
148. PATTULLO V , Ravindran NC, Mazzulli T, Wong DK, et al
     Pegylated interferon plus optimized weight-based ribavirin dosing negate the influence of weight and body mass index on early viral kinetics and sustained virological response in chronic hepatitis C.
     J Viral Hepat. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
149. PARKES J , Guha IN, Roderick P, Harris S, et al
     Enhanced Liver Fibrosis (ELF) test accurately identifies liver fibrosis in patients with chronic hepatitis C.
     J Viral Hepat. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
150. ROSENBERG P , Hagen K
     Serum B12 levels predict response to treatment with interferon and ribavirin in patients with chronic HCV infection.
     J Viral Hepat. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
151. WITTHOEFT T , Hueppe D, John C, Goelz J, et al
     Efficacy and tolerability of peginterferon alfa-2a or alfa-2b plus ribavirin in the daily routine treatment of patients with chronic hepatitis C in Germany: The PRACTICE Study.
     J Viral Hepat. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
152. DUBERG AS , Pettersson H, Aleman S, Blaxhult A, et al
     The burden of hepatitis C in Sweden: a national study of inpatient care.
     J Viral Hepat. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     January 2010
153. MAIDA I , Martin-Carbonero L, Sotgiu G, Vispo E, et al
     Differences in liver fibrosis and response to pegylated interferon plus ribavirin in HIV/HCV-coinfected patients with normal vs elevated liver enzymes.
     J Viral Hepat. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
154. WILLIAMS MJ , Lang-Lenton M
     Progression of initially mild hepatic fibrosis in patients with chronic hepatitis C infection.
     J Viral Hepat. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
155. TRELOAR C , Newland J, Rance J, Hopwood M, et al
     Uptake and delivery of hepatitis C treatment in opiate substitution treatment: perceptions of clients and health professionals.
     J Viral Hepat. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
156. SGIER C , Mullhaupt B, Gerlach T, Moradpour D, et al
     Effect of antiviral therapy on circulating cytokeratin-18 fragments in patients with chronic hepatitis C.
     J Viral Hepat. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
157. GODOY MM , Lopes EP, Silva RO, Hallwass F, et al
     Hepatitis C virus infection diagnosis using metabonomics.
     J Viral Hepat. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
158. MAWATARI H , Yoneda M, Fujita K, Nozaki Y, et al
     Association between phospholipids and free cholesterol in high-density lipoprotein and the response to hepatitis C treatment in Japanese with genotype 1b.
     J Viral Hepat. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     December 2009
159. HOLLINGER FB , Sood G
     Occult hepatitis B virus infection: a covert operation.
     J Viral Hepat. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
160. UDDIN G , Shoeb D, Solaiman S, Marley R, et al
     Prevalence of chronic viral hepatitis in people of south Asian ethnicity living in England: the prevalence cannot necessarily be predicted from the prevalence in the country of origin.
     J Viral Hepat. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
161. TANAKA M , Tanaka H, Tsukuma H, Ioka A, et al
     Risk factors for intrahepatic cholangiocarcinoma: a possible role of hepatitis B virus.
     J Viral Hepat. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     

Thank you for your interest in scientific medicine.

This service is provided by AMEDEO through an unrestricted educational grant from F. Hoffmann-La Roche.

Amedeo is a Flying Publisher website.    Design: